News & Analysis on Clinical Trial Services & Contract Research And Development
Marken is centralizing its brokerage management services in conjunction with UPS, as the rise in global trials brings more vendors and new challenges into the fold.
The India-based CRO Veeda Clinical Research has completed a second audit by the Malaysia Regulatory Agency, following 18 US FDA inspections over the past two years.
Iqvia reported a record quarter of contracted bookings during its third quarter earnings call, as the company continues to invest in its technology platform while securing new customers, say CEO.
Paid for and content provided by Marken
Virtual and hybrid clinical trials have arrived. Having learnt from pilot projects, pharma companies are systematically incorporating patient-centric services into trials, resulting in a significant minority of today’s studies featuring virtual elements.
Velesco Pharma has expanded its analytical research and development capabilities to meet a growing demand for its services after acquiring a new facility in Michigan.
CROs don’t have sufficient access to clinical research associates (CRAs) to realize market growth, says the CEO of VIARES, which is working to create a new trained and accredited workforce.
Pfizer has entered into an investment agreement with Bain Capital to spinout its neuroscience portfolio into a jointly-led company.
Recipharm has reversed its decision about its Sweden-based operations after new customers emerged making the site viable again.
GSK has opened a manufacturing plant in Montrose, Scotland, where the firm will make APIs for its Ellipta respiratory medicines.